The U.S. Food and Drug Administration announced a series of moves that aim to speed to market generic versions of complex drugs in an effort to address the rising cost of pharmaceuticals.
Commissioner Scott Gottlieb wrote about the new efforts in a blog that focused on drug prices. The moves are meant to increase competition in the market.
"Our announcements today are part of a broader effort by the administration to address the high and rising cost of drugs and in the coming months, we’ll advance other policies aimed at enabling generic competition to complex drugs," wrote Gottlieb. "We’re just getting started. Drug access is a matter of public health concern. We know that enabling more generic competition, where Congress intended, helps reduce prices, enable more access, and improve public health."
Read the Reuters report